Minnesota Medical Foundation
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
45.5%
5 terminated/withdrawn out of 11 trials
54.5%
-32.0% vs industry average
9%
1 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine
Role: collaborator
Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee
Role: collaborator
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
Role: collaborator
Functional Neuroimaging Effects of Cognitive Remediation Training
Role: collaborator
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
Role: collaborator
Preservation of Ovarian Function After Hematopoietic Cell Transplant
Role: collaborator
Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis
Role: collaborator
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Role: collaborator
A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval
Role: collaborator
Controlled Trial of Valacyclovir in Infectious Mononucleosis
Role: collaborator
Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts
Role: collaborator
All 11 trials loaded